v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities:    
Net loss $ (60,162) $ (83,778)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation and amortization 2,064 1,744
Amortization of debt discount 1,887 2,476
Change in fair value of derivatives 151 (364)
Change in fair value of share payable 414 (16)
Change in fair value of convertible notes (25,633) (7,715)
Loss from extinguishment of debt 17,397 14,393
Loss from issuance of debt 4,676 835
Amortization of operating lease right-of-use asset 273 300
Stock-based compensation for services 1,207 3,456
Warrant modifications associated with convertible notes under fair value option   327
Loss from warrant modifications   822
Non-cash financing cost   500
Subtotal of non-cash charges 2,436 16,758
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (837) 101
Other non-current assets 15 (7)
Accounts payable and accrued expenses 7,752 8,937
Related party accounts payable and accrued expenses 5,940 908
Lease liabilities 93 64
Net cash used in operating activities (44,763) (57,017)
Cash Flows from Investing Activities:    
Purchase of equipment and construction in progress (1,504) (1,014)
Loan receivable (311)  
Net cash used in investing activities (1,815) (1,014)
Cash Flows from Financing Activities:    
Proceeds from issuance of Series C convertible preferred stock   8,201
Proceeds from issuance of common shares 19,319 14,217
Proceeds from exercise of warrants 23 1,535
Proceeds from investor advance   200
Proceeds from issuance of notes payable, net 12,000 14,000
Proceeds from issuance of convertible notes payable, net 19,255 20,015
Proceeds from contingent payment obligation   50
Repayment of notes payable (259) (323)
Repayment of convertible notes payable (1,011) (1,110)
Net cash provided by financing activities 49,327 56,785
Effect of exchange rate changes on cash and cash equivalents (1,884) 1,295
Net increase in cash and cash equivalents 865 49
Cash and cash equivalents, beginning of the year 2,175 2,126
Cash and cash equivalents, end of the year 3,040 2,175
Supplemental schedule of non-cash activities:    
Cashless warrants and stock options exercise   3
Issuance of common stock for conversion of debt and accrued interest 37,027 19,408
Issuance of Series C preferred stock for conversion of debt and accrued interest   2,679
Series C convertible preferred stock conversions 2,797 14,091
Capital expenditures included in accounts payable 23 36
Deemed dividend related to warrant modifications 1,315 1,414
Debt discount related to warrant modifications   8
Offering cost related to warrant modification associated with a security purchase agreement   200
Reclassification between contingent payment obligation and convertible notes payable at fair value 3,000 300
Reclassification of liability classified warrants to equity 5,175  
Reclassification of equity classified warrants to warrant liabilities 2,643 1,007
Right-of-use asset recognized in exchange for lease liability   364
Equity contribution from acquisition of Advent 35,432  
Contract balances due to Seller - related party 7,926  
Common shares returned from acquisition 12  
Notes payable    
Supplemental disclosure of cash flow information    
Interest payments (33) (130)
Convertible notes payable    
Reconciliation of net loss to net cash used in operating activities:    
Loss from extinguishment of debt   $ (8,700)
Supplemental disclosure of cash flow information    
Interest payments (355)  
Supplemental schedule of non-cash activities:    
Issuance of Series C preferred stock for conversion of debt and accrued interest $ 1,400